Melissa Stanton
Impact in
-
- Renal cell carcinoma treatment
- Ferroptosis and cancer prognosis
- Cancer Research top 10%
- Cancer Genomics and Diagnostics
Papers in
-
- Renal cell carcinoma treatment 21
-
- Renal and related cancers 13
- Epigenetics and DNA Methylation 4
- Co-authors
- Thai H. Ho (20 shared papers)Erik P. Castle (13 shared papers)Richard W. Joseph (10 shared papers)Toni K. Choueiri (7 shared papers)Sabina Signoretti (5 shared papers)David F. McDermott (5 shared papers)Michael B. Atkins (5 shared papers)André P. Fay (5 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Human Pathology (6 papers)PLoS ONE (3 papers)Clinical Epigenetics (2 papers)Japanese Journal of Clinical Oncology (2 papers)
- Partner nations
- United StatesIndiaIsrael
In The Last Decade
Melissa Stanton
44 papers receiving 865 citations
Peers
Comparison fields: 5 of 69
- Pulmonary and Respiratory Medicine 500
- Cancer Research 228
- Oncology 363
- Surgery 229
- Molecular Biology 346
Countries citing papers authored by Melissa Stanton
This map shows the geographic impact of Melissa Stanton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Stanton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Stanton more than expected).
Fields of papers citing papers by Melissa Stanton
This network shows the impact of papers produced by Melissa Stanton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Stanton. The network helps show where Melissa Stanton may publish in the future.
Co-authors
The 25 scholars most cited alongside Melissa Stanton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 242 | |
| 2 | 2015 | 131 | |
| 3 | 2015 | 53 | |
| 4 | 2013 | 49 | |
| 5 | 2015 | 39 | |
| 6 | 2013 | 35 | |
| 7 | Constitutive activation with overexpression of the mTORC2-phospholipase D1 pathway in uterine leiomyosarcoma and STUMP: morphoproteomic analysis with therapeutic implications. | 2010 | 33 |
| 8 | 2016 | 32 | |
| 9 | Morphoproteomic analysis reveals an overexpressed and constitutively activated phospholipase D1-mTORC2 pathway in endometrial carcinoma. | 2010 | 30 |
| 10 | 2016 | 18 | |
| 11 | 2022 | 16 | |
| 12 | 2018 | 16 | |
| 13 | 2019 | 16 | |
| 14 | 2011 | 14 | |
| 15 | 2019 | 13 | |
| 16 | 2022 | 11 | |
| 17 | 2014 | 11 | |
| 18 | 2022 | 10 | |
| 19 | 2021 | 8 | |
| 20 | 2016 | 8 |
About Melissa Stanton
Melissa Stanton is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Cancer Research, Surgery and Oncology, having authored 48 papers that have together received 877 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (21 papers), Renal and related cancers (13 papers), Cancer Genomics and Diagnostics (12 papers), Bladder and Urothelial Cancer Treatments (11 papers), Urinary and Genital Oncology Studies (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Epigenetics and DNA Methylation (4 papers) and Cancer Cells and Metastasis (3 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (500 citations), Cancer Research (228 citations), Oncology (363 citations), Surgery (229 citations) and Molecular Biology (346 citations). Melissa Stanton has collaborated with scholars based in United States, India and Israel. Frequent co-authors include Thai H. Ho, Erik P. Castle, Richard W. Joseph, Toni K. Choueiri, Sabina Signoretti, David F. McDermott, Michael B. Atkins, André P. Fay, Laurence Albigès and Joaquim Bellmunt. Their work appears in journals such as Journal of Clinical Oncology, Human Pathology, PLoS ONE, Clinical Epigenetics and Japanese Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.